June 2023 updates to the website
18 July 2023
The website has now been updated following the June meeting of the LSCMMG
Levetiracetam (Keppra®) prescribing: bioequivalence and antiepileptic drugs - position statement and SOP
Antihistamine position statement (interim LSCMMG guidance)
Gluten free products position statement (interim LSCMMG guidance)
Lipid Management Pathway for Primary Prevention of Cardiovascular Disease (CVD)
Primary Care Management of Menopause - guideline and product relative cost list